Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib in Advanced NSCLC With Asymptomatic Brain Metastases
NCT00663689Phase 2Unknown
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Mar 2008
- Primary completion
- Mar 2011
01
Overview
A Phase 2 trial of erlotinib in non-small cell lung cancer (NSCLC), brain metastases, sponsored by Guangdong Provincial People's Hospital. Status: unknown.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)brain metastases
Beyond the preview
Go deeper on NCT00663689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00663689.